Researcher.Life Logo

Revista Brasileira de Hematologia e Hemoterapia : Impact Factor & More

eISSN: 1806-0870pISSN: 1516-8484
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Revista Brasileira de Hematologia e Hemoterapia Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Elsevier
Language English
Publication Time21
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorSociedade Brasileira de Hematologia e Hemoterapia
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 21
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Looking for the right journals to submit your mansucript?

Upload your manuscript and get a submission readiness score and other journal recommendations.

Check my Paper

Recently Published Papers in Revista Brasileira de Hematologia e Hemoterapia

Automated red cell exchange in acute sickle cell crises: Case series and review of the literature.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
The murine Irs1 knockout model, generated by the spontaneous Irs1S57X mutation in homozygosity, exhibits high embryonic lethality, limiting studies of adult hematopoiesis.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Socio-demographic and therapeutic profile of people living with thalassemia in Brazil between 2012 and 2022: A cross-sectional study.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Dose-dependent mortality risk of plasma transfusion in critically ill patients.
  • 23 Jun 2026
  • Hematology, transfusion and cell therapy
Automated red cell exchange in acute sickle cell crises: Case series and review of the literature.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Exploring the prognostic impact and biological functions of mutant-like TP53-related genes in acute myeloid leukemia.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
The murine Irs1 knockout model, generated by the spontaneous Irs1S57X mutation in homozygosity, exhibits high embryonic lethality, limiting studies of adult hematopoiesis.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Evaluating the treatment of patients with paroxysmal nocturnal hemoglobinuria in Brazil: disparities in access and treatment persistence.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Socio-demographic and therapeutic profile of people living with thalassemia in Brazil between 2012 and 2022: A cross-sectional study.
  • 1 Jul 2026
  • Hematology, transfusion and cell therapy
Dose-dependent mortality risk of plasma transfusion in critically ill patients.
  • 23 Jun 2026
  • Hematology, transfusion and cell therapy

FAQs on Revista Brasileira de Hematologia e Hemoterapia